PALO ALTO, Calif.--Incyte Pharmaceuticals said it has finalized an agreement to contribute to the Human Genome Project by performing DNA sequencing for the University of Washington. The university, which named Incyte as a collaborator in a grant proposal it made to the US National Human Genome Research Institute earlier this year, will refine the data Incyte generates and deposit it to GenBank. The university had requested $3 million to budget for Incyte’s sequencing services.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.